GCET2 Inhibitors
The chemical class of GCET2 inhibitors comprises a set of compounds targeting key signaling pathways to potentially modulate GCET2 activity. PD98059 and U0126 are MEK inhibitors that selectively block the activation of ERK1 and ERK2, influencing the MAPK pathway and potentially modulating GCET2 indirectly by affecting downstream signaling events. LY294002 and Wortmannin are PI3K inhibitors that block the production of phosphatidylinositol-3,4,5-trisphosphate, influencing the PI3K/AKT pathway and potentially modulating GCET2 indirectly through PI3K signaling. SB203580 and SP600125 are inhibitors targeting the p38 MAPK and JNK pathways, respectively, potentially modulating GCET2 by affecting downstream signaling events.
AZD6244 and GDC-0879 are MEK inhibitors with selectivity for MEK1 and MEK2, influencing the MAPK pathway and potentially modulating GCET2 indirectly by affecting downstream signaling events. BAY 11-7082 is an NF-κB inhibitor preventing IκB phosphorylation, influencing the NF-κB pathway and potentially modulating GCET2 indirectly through downstream signaling. AS601245 and SB202190 are p38 MAPK inhibitors targeting the activation of p38α and p38β, potentially modulating GCET2 by affecting downstream signaling events. TGX-221 is a PI3Kβ inhibitor selectively targeting the PI3K isoform p110β, influencing the PI3K/AKT pathway and potentially modulating GCET2 indirectly through PI3K signaling. This diverse set of inhibitors provides a valuable toolkit for investigating the intricate regulatory mechanisms associated with GCET2, offering insights into potential avenues for further research in this field.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that selectively blocks the activation of ERK1 and ERK2. PD98059 influences the MAPK pathway, potentially modulating GCET2 indirectly by affecting downstream signaling events. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that blocks the production of phosphatidylinositol-3,4,5-trisphosphate. LY294002 influences the PI3K/AKT pathway, potentially modulating GCET2 indirectly through PI3K signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor blocking the production of phosphatidylinositol-3,4,5-trisphosphate. Wortmannin influences the PI3K/AKT pathway, potentially modulating GCET2 indirectly through PI3K signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor blocking the activation of p38. SB203580 influences the p38 MAPK pathway, potentially modulating GCET2 indirectly by affecting downstream signaling events. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor targeting the c-Jun N-terminal kinases. SP600125 influences the JNK pathway, potentially modulating GCET2 indirectly by affecting downstream signaling events. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
MEK inhibitor that selectively inhibits MEK1 and MEK2. AZD6244 influences the MAPK pathway, potentially modulating GCET2 indirectly by affecting downstream signaling events. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB inhibitor preventing IκB phosphorylation. BAY 11-7082 influences the NF-κB pathway, potentially modulating GCET2 indirectly by affecting downstream signaling events. | ||||||
GDC-0879 | 905281-76-7 | sc-364497 | 5 mg | $225.00 | ||
RAF kinase inhibitor with selectivity for BRAF. GDC-0879 influences the MAPK pathway, potentially modulating GCET2 indirectly by affecting downstream signaling events. | ||||||
PI 3-Kβ Inhibitor VI, TGX-221 | 663619-89-4 | sc-203190 | 1 mg | $437.00 | ||
PI3Kβ inhibitor selectively targeting the PI3K isoform p110β. TGX-221 influences the PI3K/AKT pathway, potentially modulating GCET2 indirectly through PI3K signaling. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
p38 MAPK inhibitor blocking the activation of p38. SB202190 influences the p38 MAPK pathway, potentially modulating GCET2 indirectly by affecting downstream signaling events. | ||||||